JP2016517882A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016517882A5 JP2016517882A5 JP2016511708A JP2016511708A JP2016517882A5 JP 2016517882 A5 JP2016517882 A5 JP 2016517882A5 JP 2016511708 A JP2016511708 A JP 2016511708A JP 2016511708 A JP2016511708 A JP 2016511708A JP 2016517882 A5 JP2016517882 A5 JP 2016517882A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- carrier
- weight
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 15
- 239000003410 keratolytic agent Substances 0.000 claims 13
- 150000003904 phospholipids Chemical class 0.000 claims 13
- 239000013543 active substance Substances 0.000 claims 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims 4
- 239000004202 carbamide Substances 0.000 claims 4
- 239000002537 cosmetic Substances 0.000 claims 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 4
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 230000000144 pharmacologic effect Effects 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 229960000458 allantoin Drugs 0.000 claims 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 230000001166 anti-perspirative effect Effects 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 239000003213 antiperspirant Substances 0.000 claims 2
- 239000003581 cosmetic carrier Substances 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 2
- 239000004310 lactic acid Substances 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- 239000001630 malic acid Substances 0.000 claims 2
- 235000011090 malic acid Nutrition 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- 238000005507 spraying Methods 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- 208000001840 Dandruff Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000000058 anti acne agent Substances 0.000 claims 1
- 229940124340 antiacne agent Drugs 0.000 claims 1
- 239000003699 antiulcer agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000002831 pharmacologic agent Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1300318 | 2013-05-03 | ||
| SE1300318-1 | 2013-05-03 | ||
| PCT/SE2014/050546 WO2014178789A1 (en) | 2013-05-03 | 2014-05-02 | Topical composition and carrier for administration of pharmaceutical or cosmetic active ingredients |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016517882A JP2016517882A (ja) | 2016-06-20 |
| JP2016517882A5 true JP2016517882A5 (cg-RX-API-DMAC7.html) | 2017-06-15 |
| JP6595454B2 JP6595454B2 (ja) | 2019-10-23 |
Family
ID=51843780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016511708A Active JP6595454B2 (ja) | 2013-05-03 | 2014-05-02 | 薬学的又は化粧学的活性成分を投与するための局部用組成物及びキャリアー |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160081916A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2991681B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6595454B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105682686A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014260509B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015027436A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2909995C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2985790T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1222337A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2715103C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014178789A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2496263T (pt) | 2009-11-03 | 2022-03-28 | Lipidor Ab | Composição que forma uma camada lipídica para administração sobre uma superfície de um organismo vivo |
| SE1300709A1 (sv) * | 2013-11-14 | 2015-05-15 | Lipidor Ab | Komposition och metod för topikal behandling |
| EP3068437B2 (en) * | 2013-11-14 | 2022-07-06 | Lipidor AB | Sprayable topical carrier and composition comprising phosphatidylcholine |
| GB201511799D0 (en) * | 2015-07-06 | 2015-08-19 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| DK3654932T3 (da) * | 2017-07-20 | 2022-01-17 | Thomas Leibbrand | Tyrothricin til anvendelse ved behandling eller forebyggelse af kropslugt og præparater hertil |
| US20250099369A1 (en) * | 2023-09-27 | 2025-03-27 | Andros Pharmaceuticals Co., Ltd. | Topical delivery compositions comprising non-steroidal anti-inflammatory drugs |
| WO2025088126A1 (en) * | 2023-10-27 | 2025-05-01 | Lipidor Ab | Topical composition comprising at least two lipids |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3069319A (en) * | 1959-10-14 | 1962-12-18 | American Cyanamid Co | Sprayable composition |
| US3456052A (en) * | 1965-09-28 | 1969-07-15 | Garrett Lab Inc | Aerosol composition containing butoxymonoether of a polyoxyalkylene glycol |
| JPS5815909A (ja) * | 1981-07-22 | 1983-01-29 | Toko Yakuhin Kogyo Kk | 抗真菌外用剤 |
| US4542129A (en) * | 1982-08-16 | 1985-09-17 | Norman Orentreich | DHEA Formulations and methods for treating dry skin |
| DE4021084C1 (en) * | 1990-07-03 | 1991-11-21 | Hans Dr. 5024 Pulheim De Lautenschlaeger | Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant |
| GB9023701D0 (en) * | 1990-10-31 | 1990-12-12 | Efamol Holdings | Medical treatment |
| IT1269634B (it) * | 1994-05-06 | 1997-04-08 | Indena Spa | Medicamento topico ad attivita' cicatrizzante |
| US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| ES2200144T3 (es) * | 1996-12-13 | 2004-03-01 | Vesifact Ag | Preparaciones cosmeticas. |
| US6168798B1 (en) * | 1997-02-03 | 2001-01-02 | Bristol-Myers Squibb Company | Non-irritating composition for treating acne and other skin conditions |
| WO1998051273A1 (en) * | 1997-05-12 | 1998-11-19 | Sage Pharmaceuticals, Inc. | Topical spray for burn treatment and anti-infection |
| PE20011092A1 (es) * | 2000-02-14 | 2001-11-12 | Procter & Gamble | Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel |
| US7074392B1 (en) * | 2000-03-27 | 2006-07-11 | Taro Pharmaceutical Industries Limited | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections |
| DE10024413A1 (de) * | 2000-05-19 | 2001-12-06 | Mika Pharma Gmbh | Pharmazeutische und/oder kosmetische Zubereitung |
| DE10036051A1 (de) * | 2000-07-25 | 2002-02-07 | Beiersdorf Ag | Kosmetische oder dermatologische Formulierungen zur Pflege und Kühlung der Haut nach einem Sonnenbad |
| FR2856301B1 (fr) * | 2003-06-23 | 2007-08-03 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
| US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US9308268B2 (en) * | 2005-02-14 | 2016-04-12 | Transdermal Corp | Solubilized benzoyl peroxyde acne |
| US20070154402A1 (en) * | 2005-10-24 | 2007-07-05 | Collegium Pharmaceutical, Inc. | Topical Pharmaceutical Foam Composition |
| JP5371235B2 (ja) * | 2006-12-06 | 2013-12-18 | ロート製薬株式会社 | 皮膚外用剤 |
| ES2583163T3 (es) * | 2007-10-02 | 2016-09-19 | Kuhs Gmbh | Composición cosmética o farmacéutica para aplicación tópica |
| WO2009101412A1 (en) * | 2008-02-13 | 2009-08-20 | Cipla Limited | Topical pharmaceutical composition |
| DK2344198T3 (da) * | 2008-09-27 | 2020-11-30 | Jina Pharmaceuticals Inc | Lipidbaserede farmaceutiske præparater til topisk anvendelse |
| PT2496263T (pt) * | 2009-11-03 | 2022-03-28 | Lipidor Ab | Composição que forma uma camada lipídica para administração sobre uma superfície de um organismo vivo |
| US20120213843A1 (en) * | 2009-11-03 | 2012-08-23 | Lipidor Ab | Composition for promoting wound healing |
| CN101829052B (zh) * | 2010-03-16 | 2011-12-14 | 王国强 | 紫杉烷类化合物的自乳化制剂及其制备方法 |
| AU2012251135A1 (en) * | 2011-05-02 | 2013-11-07 | Lipidor Ab | Treatment of psoriasis |
| SE1300709A1 (sv) * | 2013-11-14 | 2015-05-15 | Lipidor Ab | Komposition och metod för topikal behandling |
| WO2012150890A1 (en) * | 2011-05-02 | 2012-11-08 | Lipidor Ab | Antibacterial composition |
| EP3068437B2 (en) * | 2013-11-14 | 2022-07-06 | Lipidor AB | Sprayable topical carrier and composition comprising phosphatidylcholine |
-
2014
- 2014-05-02 JP JP2016511708A patent/JP6595454B2/ja active Active
- 2014-05-02 BR BR112015027436A patent/BR112015027436A8/pt not_active Application Discontinuation
- 2014-05-02 CA CA2909995A patent/CA2909995C/en active Active
- 2014-05-02 AU AU2014260509A patent/AU2014260509B2/en active Active
- 2014-05-02 CN CN201480024608.6A patent/CN105682686A/zh active Pending
- 2014-05-02 CN CN202110687912.0A patent/CN113648278A/zh active Pending
- 2014-05-02 EP EP14792127.4A patent/EP2991681B1/en active Active
- 2014-05-02 RU RU2015149340A patent/RU2715103C2/ru active
- 2014-05-02 ES ES14792127T patent/ES2985790T3/es active Active
- 2014-05-02 HK HK16110612.9A patent/HK1222337A1/zh unknown
- 2014-05-02 US US14/787,631 patent/US20160081916A1/en not_active Abandoned
- 2014-05-02 WO PCT/SE2014/050546 patent/WO2014178789A1/en not_active Ceased
-
2024
- 2024-05-15 US US18/664,525 patent/US20240307294A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016517882A5 (cg-RX-API-DMAC7.html) | ||
| JP2013511534A5 (cg-RX-API-DMAC7.html) | ||
| JPS63500171A (ja) | 経皮流動を減少せしめたるための医薬ビヒクル | |
| ES2244625T3 (es) | Uso de derivados de biguanida para la fabricacion de un medicamento con efecto cicatrizante. | |
| US20140161912A1 (en) | Compositions and methods for tissue regeneration | |
| JP2010535198A (ja) | コハク酸のコリン塩を含む鼻腔内投与用医薬品組成物 | |
| RU2015149340A (ru) | Местная композиция и носитель для введения фармацевтически или косметически активных ингредиентов | |
| KR20150025286A (ko) | 피토스핑고신-1-포스페이트 또는 그 유도체를 포함하는 아토피 또는 피부상처 치료 또는 예방용 조성물 | |
| KR20250143851A (ko) | 신규한 다기능성 올리고펩타이드 | |
| TW200940062A (en) | Combination comprising paclitaxel for treating ovarian cancer | |
| TW201309298A (zh) | 治療惡性神經膠質瘤之醫藥組合物 | |
| JP6507180B2 (ja) | ボルドおよびセイヨウナツユキソウエキスを含む動物向けの局所組成物およびその使用 | |
| CN107519236A (zh) | 一种治疗灰指甲的外用药剂 | |
| CN103181894B (zh) | 萘丁美酮喷雾剂及其制备方法 | |
| ES2880437T3 (es) | Nuevas composiciones tópicas que comprenden ácido úsnico y su uso terapéutico | |
| CZ868686A3 (en) | Primicin-containing colloidal elementary gel, and process for preparing thereof | |
| CN104856977B (zh) | 一种治疗牛羊真菌感染性皮肤病的外用涂膜剂 | |
| CN103816112B (zh) | 一种复方丹参凝胶剂的制备方法 | |
| WO2024239066A1 (en) | Pharmaceutical composition | |
| CN102247374A (zh) | 四氢嘧啶及其衍生物在制备治疗皮肤创伤的药物中的应用 | |
| CN102085199B (zh) | 治疗类风湿性关节炎的透皮吸收生物贴剂及其制备方法 | |
| US10835615B2 (en) | Supramolecular hydrogels containing angiotensin receptor blockers for targeted treatment of diabetic wounds | |
| JP6549107B2 (ja) | がんの処置のための、ｒｏ５５０３７８１、カペシタビン及びオキサリプラチンの組み合わせ | |
| CN101518514A (zh) | 硝酸益康唑微乳气雾剂及其制备方法 | |
| JP2022020671A (ja) | パ－キンソン病治療用の新規高透過薬物及びその組成物 |